Research Insight
Research Insight
AbbVie and Johns Hopkins to Collaborate on Cancer Research
AbbVie, a global biopharmaceutical company, and the Johns Hopkins University School of Medicine today announced that they signed a five-year collaboration agreement with the goal...
Research Insight
Blueprint Medicines Announces Proof-of-Concept Data from Global Phase 1 Clinical Trial of BLU-554
Blueprint Medicines Corporation , a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases announced data from its ongoing Phase...
Research Insight
Novartis BAF312 reduces the risk of disability progression in phase III study in secondary patients
EXPAND study data presented at ECTRIMS show that treatment with BAF312 (siponimod) reduced the risk of three-month confirmed disability progression by 21% vs placebo in...
Research Insight
Merck to Develop Next-Generation Purification Processes with International Vaccine Institute
Merck, a leading science and technology company, has entered a research agreement with the International Vaccine Institute (IVI) of Seoul, South Korea to help develop...
Research Insight
Johnson & Johnson Pharmaceutica NV Idylla Ebola Virus Triage Test Granted Emergency Use Authorizatio
Johnson & Johnson’s commitment to combat Ebola, Janssen Pharmaceutica NV announced that the Idylla™ Ebola Virus Triage Test (Idylla™ EBOV Test) was granted Emergency Use...
Research Insight
Bayer collaborates with US NSAB Project Investigate Additional Adjuvant Therapy in Colon Cancer
Bayer and the U.S. National Surgical Adjuvant Breast and Bowel Project (NSABP), a leading clinical trials cooperative group, are collaborating on a new Phase III...
Research Insight
Bayer Terminates Phase II Study with Riociguat in Patients with Pulmonary Hypertension Associated wi
Following the recommendation of an independent Data Monitoring Committee (DMC), Bayer is terminating its Phase II study investigating riociguat in patients with pulmonary hypertension associated...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
